Shanghai Medicilon Inc. (SHA:688202)
China
· Delayed Price · Currency is CNY 65.75
-1.80 (-2.66%)
At close: Apr 29, 2026
Shanghai Medicilon Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,163 | 1,037 | 1,366 | 1,659 | 1,167 | Upgrade
|
| Other Revenue | 0.12 | 0.46 | 0.03 | 0.06 | 0.76 | Upgrade
|
| Revenue | 1,163 | 1,038 | 1,366 | 1,659 | 1,167 | Upgrade
|
| Revenue Growth (YoY) | 12.08% | -24.01% | -17.68% | 42.12% | 75.28% | Upgrade
|
| Cost of Revenue | 970.53 | 1,008 | 1,060 | 983.57 | 639.5 | Upgrade
|
| Gross Profit | 192.53 | 30.04 | 305.74 | 675.36 | 527.76 | Upgrade
|
| Selling, General & Admin | 205.43 | 191.65 | 220.18 | 204.09 | 132.28 | Upgrade
|
| Research & Development | 104.41 | 96.73 | 122.39 | 122.88 | 77.76 | Upgrade
|
| Other Operating Expenses | 1.24 | 3.01 | 3.28 | 2.28 | 0.73 | Upgrade
|
| Operating Expenses | 377.31 | 401.84 | 389.92 | 352.76 | 219.29 | Upgrade
|
| Operating Income | -184.78 | -371.8 | -84.17 | 322.6 | 308.47 | Upgrade
|
| Interest Expense | -9.51 | -8.36 | -9.66 | -4.88 | -2.01 | Upgrade
|
| Interest & Investment Income | 15.95 | 20.19 | 8.86 | 4.6 | 7.41 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.96 | 7.59 | -0.32 | 12.39 | -3.57 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.16 | -12.08 | -0.4 | 0.04 | -0.79 | Upgrade
|
| EBT Excluding Unusual Items | -183.45 | -364.47 | -85.69 | 334.74 | 309.51 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.73 | -5.13 | 3.23 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.95 | -1.12 | -0.34 | -0.87 | -1.04 | Upgrade
|
| Asset Writedown | -5.13 | -18.42 | - | - | - | Upgrade
|
| Other Unusual Items | 1.81 | 8.07 | 23.69 | 34.25 | 14.44 | Upgrade
|
| Pretax Income | -185 | -381.08 | -59.1 | 368.11 | 322.91 | Upgrade
|
| Income Tax Expense | -17.17 | -50.23 | -25.89 | 29.87 | 38.26 | Upgrade
|
| Earnings From Continuing Operations | -167.83 | -330.85 | -33.21 | 338.24 | 284.65 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -2.42 | Upgrade
|
| Net Income | -167.83 | -330.85 | -33.21 | 338.24 | 282.22 | Upgrade
|
| Net Income to Common | -167.83 | -330.85 | -33.21 | 338.24 | 282.22 | Upgrade
|
| Net Income Growth | - | - | - | 19.85% | 118.12% | Upgrade
|
| Shares Outstanding (Basic) | 132 | 134 | 128 | 122 | 122 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 134 | 128 | 122 | 122 | Upgrade
|
| Shares Change (YoY) | -1.34% | 4.86% | 4.98% | 0.08% | 0.19% | Upgrade
|
| EPS (Basic) | -1.27 | -2.47 | -0.26 | 2.78 | 2.32 | Upgrade
|
| EPS (Diluted) | -1.27 | -2.47 | -0.26 | 2.78 | 2.32 | Upgrade
|
| EPS Growth | - | - | - | 19.75% | 117.71% | Upgrade
|
| Free Cash Flow | 36.14 | -133.14 | -152.36 | -425.39 | 160.22 | Upgrade
|
| Free Cash Flow Per Share | 0.27 | -0.99 | -1.19 | -3.50 | 1.32 | Upgrade
|
| Dividend Per Share | - | - | - | 0.279 | 0.699 | Upgrade
|
| Dividend Growth | - | - | - | -60.14% | 117.49% | Upgrade
|
| Gross Margin | 16.55% | 2.90% | 22.39% | 40.71% | 45.21% | Upgrade
|
| Operating Margin | -15.89% | -35.83% | -6.16% | 19.45% | 26.43% | Upgrade
|
| Profit Margin | -14.43% | -31.88% | -2.43% | 20.39% | 24.18% | Upgrade
|
| Free Cash Flow Margin | 3.11% | -12.83% | -11.16% | -25.64% | 13.73% | Upgrade
|
| EBITDA | -93.71 | -279.52 | 1.36 | 384.14 | 354.49 | Upgrade
|
| EBITDA Margin | -8.06% | -26.94% | 0.10% | 23.16% | 30.37% | Upgrade
|
| D&A For EBITDA | 91.08 | 92.28 | 85.53 | 61.54 | 46.01 | Upgrade
|
| EBIT | -184.78 | -371.8 | -84.17 | 322.6 | 308.47 | Upgrade
|
| EBIT Margin | -15.89% | -35.83% | -6.16% | 19.45% | 26.43% | Upgrade
|
| Effective Tax Rate | - | - | - | 8.11% | 11.85% | Upgrade
|
| Revenue as Reported | 1,163 | 1,038 | 1,366 | 1,659 | 1,167 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.